PP
ACIU icon

PDT Partners’s AC Immune ACIU Stock Holding History

PDT Partners’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-29,093
Closed -$195K – 855
2021
Q3 		$195K Sell
29,093
-4,800
-14% -$34.4K 0.01% 696
2021
Q2 		$269K Sell
33,893
-2,907
-8% -$20.1K 0.02% 637
2021
Q1 		$280K Sell
36,800
-18,740
-34% -$134K 0.02% 632
2020
Q4 		$287K Buy
55,540
+22,631
+69% +$115K 0.02% 554
2020
Q3 		$161K Buy
32,909
+11,496
+54% +$82.5K 0.01% 650
2020
Q2 		$144K Buy
+21,413
New +$156K 0.01% 610

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

PDT Partners's ACIU Position: Q4 2021 in Review

PDT Partners sold out of AC Immune (ACIU) in Q4 2021, closing a stake of 29,093 shares — an estimated $195K sold.

PDT Partners first reported a position in ACIU in Q2 2020 and held it in 6 quarters. The position peaked at $287K in Q4 2020. 44 funds tracked by Wall St. Rank hold ACIU as of Q4 2021.

  • PDT Partners reported no remaining AC Immune position as of Q4 2021 after selling out during the quarter.
  • PDT Partners sold 29,093 AC Immune shares in Q4 2021, an estimated $195K.
  • PDT Partners first reported a position in AC Immune in Q2 2020 and held it in 6 quarters.
  • PDT Partners's AC Immune position peaked at $287K in Q4 2020.
  • 44 funds tracked by Wall St. Rank held AC Immune as of Q4 2021.

Based on PDT Partners's 13F filing for Q4 2021, filed 14 Feb 2022.